kabutan

Delta-Fly Pharma, Inc.(4598) Financial Results

4598
TSE Growth
Delta-Fly Pharma, Inc.
518
JPY
+6
(+1.17%)
Dec 5, 1:26 pm JST
3.34
USD
Dec 4, 11:26 pm EST
Result
PTS
outside of trading hours
518.4
Dec 5, 1:26 pm JST
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2022 300 -961 -964 -967 -178.6 0 May 13, 2022 J-GAAP
Mar, 2023 0 -1,315 -1,325 -1,328 -234.5 0 May 15, 2023 J-GAAP
Mar, 2024 0 -1,403 -1,426 -1,429 -198.8 0 May 15, 2024 J-GAAP
Mar, 2025 0 -1,708 -1,718 -1,721 -195.6 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance ー -1,500 -1,510 -1,512 -128.4 0 May 15, 2025 J-GAAP
YoY － +12.2% +12.1% +12.1% +34.3%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 902 -243 323 305 57,189
Fiscal Year Mar, 2017 Mar, 2018 Mar, 2017 Mar, 2017 Mar, 2017
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2022 0 -704 -705 -706 -124.7 0 May 15, 2023 J-GAAP
Oct - Mar, 2023 0 -810 -827 -829 -115.3 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 0 -792 -803 -804 -91.4 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance ー -669 -670 -671 -57.0 0 Nov 14, 2025 J-GAAP
YoY － +15.5% +16.6% +16.5% +37.6%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2023 -1,315 -1,303 -1,303 0 882 844 93.16 J-GAAP
Mar, 2024 -1,403 -1,279 -1,279 0 1,853 1,417 96.13 J-GAAP
Mar, 2025 -1,708 -1,834 -1,834 0 756 338 77.88 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 0 -593 -599 -600 -91.9 ー Nov 13, 2023 J-GAAP
Apr - Sep, 2024 0 -916 -915 -917 -111.4 ー Nov 14, 2024 J-GAAP
Apr - Sep, 2025 0 -831 -840 -841 -77.0 ー Nov 14, 2025 J-GAAP
YoY － +9.3% +8.2% +8.3% +30.9%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 0 -356 -372 -372 -54.4 -Inf Feb 13, 2024 J-GAAP
Jan - Mar, 2024 0 -454 -455 -457 -63.6 -Inf May 15, 2024 J-GAAP
Apr - Jun, 2024 0 -497 -499 -500 -60.8 -Inf Aug 9, 2024 J-GAAP
Jul - Sep, 2024 0 -419 -416 -417 -50.7 -Inf Nov 14, 2024 J-GAAP
Oct - Dec, 2024 0 -377 -390 -390 -45.9 -Inf Feb 14, 2025 J-GAAP
Jan - Mar, 2025 0 -415 -413 -414 -47.1 -Inf May 15, 2025 J-GAAP
Apr - Jun, 2025 0 -358 -366 -367 -35.4 -Inf Aug 8, 2025 J-GAAP
Jul - Sep, 2025 0 -473 -474 -474 -43.4 -Inf Nov 14, 2025 J-GAAP
YoY － -12.9% -13.9% -13.7% +14.3%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 200 -82 -89 -89 -19.3
Fiscal Year Mar, 2021 Mar, 2021 Mar, 2021 Mar, 2021 Mar, 2021
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2023 123.91 87.1 906 789 -6,780 ー May 15, 2023 J-GAAP
Mar, 2024 149.69 83.5 1,474 1,231 -8,210 ー May 15, 2024 J-GAAP
Mar, 2025 28.36 63.4 434 275 -9,931 ー May 15, 2025 J-GAAP
Apr - Sep, 2025 ー 69.3 508 352 -10,773 ー Nov 14, 2025 J-GAAP